Highland Therapeutics nets $50 mln in debt and equity funding
Canadian pharmaceutical company Highland Therapeutics Inc has secured US$50 million in financing. The deal includes a US$25 million equity investment by Eastern Capital, a Cayman Islands life sciences investor, as well as a US$25 million credit facility provided by Citibank NA. Highland Therapeutics, which is based in Toronto, said the deal's proceeds will be used to complete clinical development of its lead drug products, secure manufacturing capacity, engage in pre-marketing and medical education activities, and pursue pipeline expansion opportunities. Founded in 2008, the company is a client of Canadian innovation hub MaRS Discovery District.
24 June 2015•4 mins read
